8-K: CTS Corporation Reports Mixed Q1 2024 Results Amidst Market Shifts

CTS Corporation announced first quarter 2024 results with sales down 14% year-over-year but showing some sequential improvement, alongside a decrease in net income.

Summary

• CTS Corporation's first quarter 2024 sales were $125.7 million, a 14% decrease year-over-year but a 1% increase sequentially from the fourth quarter of 2023.
• Sales to non-transportation end markets decreased by 17% year-over-year but increased by 7% sequentially.
• Sales to the transportation end market decreased by 10% year-over-year and 4% sequentially.
• Net income for the quarter was $11 million, or 9% of sales, down from $18 million, or 13% of sales, in the first quarter of 2023.
• Earnings per diluted share were $0.36, compared to $0.58 in the first quarter of 2023.
• Adjusted earnings per diluted share were $0.47, down from $0.61 in the first quarter of 2023.
• The adjusted EBITDA margin was 20.3%, compared to 21.9% in the first quarter of 2023.
• Operating cash flow was $18 million, up from $11 million in the first quarter of 2023.
• The company is maintaining its full-year 2024 guidance for sales between $530 and $570 million and adjusted diluted EPS between $2.10 and $2.35.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative due to mixed results. While there are positive signs like sequential growth in some areas and improved cash flow, the year-over-year declines in sales and earnings are concerning. The company is maintaining its guidance, which provides some stability, but the overall tone is cautious.

Positives

• CTS saw a 1% sequential increase in overall sales compared to the previous quarter.
• Non-transportation sales increased by 7% sequentially, indicating growth in those markets.
• Operating cash flow increased to $18 million, up from $11 million in the same quarter last year.
• The adjusted gross margin improved to 36.2%, up 86 bps year-over-year and 205 bps sequentially.
• The company generated $14 million in free cash flow.
• The book-to-bill ratio for non-transportation end markets was 1.11, indicating strong demand.
• CTS added 8 new customers in the non-transportation sector.
• The company returned $13 million to shareholders through share repurchases and dividends.

Negatives

• Overall sales decreased by 14% year-over-year.
• Net income decreased to $11 million from $18 million in the same quarter last year.
• Adjusted earnings per diluted share decreased to $0.47 from $0.61 year-over-year.
• The adjusted EBITDA margin decreased to 20.3% from 21.9% year-over-year.
• Transportation sales decreased by 10% year-over-year and 4% sequentially.
• Non-transportation sales decreased by 17% year-over-year.

Risks

• The company faces risks related to supply chain disruptions.
• Changes in the economy, including inflationary or recessionary conditions, could impact the business.
• There are risks associated with integrating acquisitions.
• Rapid technological change could affect the company's products and services.
• The company is exposed to general market conditions in the transportation, industrial, aerospace and defense, and medical markets.
• Reliance on key customers poses a risk.
• Unanticipated public health crises, natural disasters, or other events could disrupt operations.
• Environmental compliance and remediation expenses could impact financials.
• The company faces risks associated with international operations, including trade and tariff barriers, exchange rates, and political and geopolitical risks.
• The company is exposed to pricing pressures and demand for its products.
• Cybersecurity incidents could affect the business.

Future Outlook

CTS is maintaining its full-year 2024 guidance for sales between $530 and $570 million and adjusted diluted EPS between $2.10 and $2.35. The company expects continued progress in medical, aerospace and defense end markets, recovery in the industrial end market in the second half of 2024, and softness in commercial vehicle-related sales.

Management Comments

• Kieran OSullivan, CEO of CTS Corporation, stated that the company achieved sales and earnings in line with expectations.
• The CEO noted that teams made progress on operational improvements in the first quarter, which helped offset the unfavorable impact from lower volumes.
• The CEO mentioned seeing some early signs of recovery in the industrial end market.
• Management emphasized the focus on future growth through continued diversification of the customer base and building the pipeline of opportunities.
• Management reiterated their commitment to a disciplined capital structure to support organic growth, strategic acquisitions, and returning cash to shareholders.

Industry Context

The results reflect a mixed performance in the current economic environment, with some sectors showing signs of recovery while others face headwinds. The transportation sector, particularly commercial vehicles and light vehicles in China, is experiencing softness, while other sectors like medical and aerospace & defense are showing more positive trends. This highlights the importance of diversification for CTS.

Comparison to Industry Standards

• While CTS's adjusted gross margin of 36.2% shows improvement, it is important to compare this to peers in the electronic components and sensor manufacturing industry. Companies like TE Connectivity (TEL) and Amphenol (APH) often report gross margins in the 30-40% range, so CTS is within a comparable range.
• CTS's adjusted EBITDA margin of 20.3% is also within the range of industry peers, but it is important to note that companies like Sensata Technologies (ST) often report higher EBITDA margins, sometimes exceeding 25%.
• The sequential improvement in non-transportation sales is a positive sign, but the year-over-year decline in overall sales is a concern. Companies with strong diversification and exposure to growing sectors like medical and aerospace are generally performing better in the current market.
• CTS's book-to-bill ratio of 1.11 for non-transportation end markets is a positive indicator of future demand, but it is important to monitor this metric against industry averages and competitors' performance.
• The company's free cash flow of $14 million is a positive sign, but it is important to compare this to the company's historical performance and the cash flow generation of its peers.

Stakeholder Impact

• Shareholders may be concerned about the year-over-year declines in sales and earnings, but the maintained guidance and improved cash flow may provide some reassurance.
• Employees may be affected by restructuring activities and changes in the company's strategy.
• Customers may be impacted by changes in the company's product offerings and pricing.
• Suppliers may be affected by changes in the company's supply chain and procurement practices.
• Creditors may be impacted by changes in the company's financial performance and debt levels.

Next Steps

• The company will hold a conference call on May 1, 2024, to discuss the financial results.
• CTS will continue to focus on diversifying its customer base and building its pipeline of opportunities.
• The company will continue to focus on operational improvements.
• CTS will continue to monitor market conditions and adjust its strategy as needed.

Key Dates

Keywords

CTS Corporation, financial results, earnings, sales, EBITDA, adjusted EPS, transportation, industrial, aerospace, medical, book-to-bill, cash flow, diversification, sensors, actuators, electronic components